Polymyositis
Silica dust, heavy metal, solvents may contribute to myositis with lung involvement
Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, especially more severe forms involving the lungs, according to data published in Arthritis Care & Research.
RA, fibromyalgia impact patients with osteoarthritis ‘quite substantially over time’
Rheumatoid arthritis and fibromyalgia are among the most common comorbidities identified in patients following a diagnosis of osteoarthritis, according to data presented at the EULAR 2024 Congress.
JAK inhibition ‘promising,’ could reduce steroid use in dermatomyositis
Earlier this year, a group of researchers published data from long-term extension study of tofacitinib in patients with dermatomyositis, demonstrating a “sustained response” to a pan-JAK inhibitor in this population.
Polymyositis diagnoses ‘exceedingly rare’ in shift toward inclusion body myositis
SAN DIEGO — Many patients who might have previously been diagnosed with polymyositis are now being treated for inclusion body myositis, according to a speaker at the Congress of Clinical Rheumatology West.
Specialized physiotherapy may improve sexual health in women with systemic sclerosis
Specialized physical therapy may prevent deterioration and improve sexual function in female patients with systemic sclerosis and idiopathic inflammatory myopathies, according to data presented at the EULAR 2022 Congress.
Myositis Awareness Month sheds light on patient voices, disease costs
Myositis Awareness Month is focused on raising awareness and amplifying voices for patients with diseases falling under the myositis umbrella.
Dermatomyositis incidence, prevalence higher than previously reported
Using the most recent EULAR/American College of Rheumatology criteria, researchers at the Mayo Clinic and the Karolinska Institute determined that the incidence and prevalence of dermatomyositis are higher than previously reported.
Increased cost of idiopathic inflammatory myopathies begins 2 years before diagnosis
The mean annual direct and indirect costs related to idiopathic inflammatory myopathies are three to five times higher than in the general population, and begin increasing 2 years before diagnosis, according to data from a Swedish registry.
Extensive assessment critical to dispel 'ambiguity' mimics in juvenile dermatomyositis
Juvenile dermatomyositis challenges rheumatologists to accurately assess not only the skin but also pulmonary and cardiac function in making a diagnosis, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.
Novel scoring system may help sort out heterogeneity of myositis
While a novel scoring system may aid in diagnosing myositis, the heterogeneity of this group of conditions presents ongoing challenges for clinicians, according to a presenter at the 2020 Congress of Clinical Rheumatology-East.